0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Capecitabine Tablets Market Research Report 2026
Published Date: 2026-03-16
|
Report Code: QYRE-Auto-33F17382
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Capecitabine Tablets Market Research Report 2024
BUY CHAPTERS

Global Capecitabine Tablets Market Research Report 2026

Code: QYRE-Auto-33F17382
Report
2026-03-16
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Capecitabine Tablets Market

The global Capecitabine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Capecitabine Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Capecitabine Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Capecitabine Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Capecitabine Tablets include Roche, Teva Pharmaceutical, Accord Healthcare, Dr. Reddy's Laboratories, Eugia Pharma, Sun Pharma, Qilu Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Shanghai Sine Pharmaceutical, Chengdu Easton Biopharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Capecitabine Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Capecitabine Tablets. The Capecitabine Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Capecitabine Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Capecitabine Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Capecitabine Tablets Market Report

Report Metric Details
Report Name Capecitabine Tablets Market
Segment by Type
  • 150mg
  • 500mg
by Application
  • Colon Cancer
  • Breast Cancer
  • Stomach Cancer
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Teva Pharmaceutical, Accord Healthcare, Dr. Reddy's Laboratories, Eugia Pharma, Sun Pharma, Qilu Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Shanghai Sine Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shandong New Time Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Capecitabine Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Capecitabine Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Capecitabine Tablets Market report?

Ans: The main players in the Capecitabine Tablets Market are Roche, Teva Pharmaceutical, Accord Healthcare, Dr. Reddy's Laboratories, Eugia Pharma, Sun Pharma, Qilu Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Shanghai Sine Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shandong New Time Pharmaceutical

What are the Application segmentation covered in the Capecitabine Tablets Market report?

Ans: The Applications covered in the Capecitabine Tablets Market report are Colon Cancer, Breast Cancer, Stomach Cancer

What are the Type segmentation covered in the Capecitabine Tablets Market report?

Ans: The Types covered in the Capecitabine Tablets Market report are 150mg, 500mg

1 Capecitabine Tablets Market Overview
1.1 Product Definition
1.2 Capecitabine Tablets by Type
1.2.1 Global Capecitabine Tablets Market Value by Type: 2025 vs 2032
1.2.2 150mg
1.2.3 500mg
1.3 Capecitabine Tablets by Application
1.3.1 Global Capecitabine Tablets Market Value by Application: 2025 vs 2032
1.3.2 Colon Cancer
1.3.3 Breast Cancer
1.3.4 Stomach Cancer
1.4 Global Capecitabine Tablets Market Size Estimates and Forecasts
1.4.1 Global Capecitabine Tablets Revenue 2021–2032
1.4.2 Global Capecitabine Tablets Sales 2021–2032
1.4.3 Global Capecitabine Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Capecitabine Tablets Market Competition by Manufacturers
2.1 Global Capecitabine Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Capecitabine Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Capecitabine Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Capecitabine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Capecitabine Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Capecitabine Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Capecitabine Tablets, Date of Entry into the Industry
2.8 Global Capecitabine Tablets Market Competitive Situation and Trends
2.8.1 Global Capecitabine Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Capecitabine Tablets Players Market Share by Revenue
2.8.3 Global Capecitabine Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Capecitabine Tablets Market Scenario by Region
3.1 Global Capecitabine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Capecitabine Tablets Sales by Region: 2021–2032
3.2.1 Global Capecitabine Tablets Sales by Region: 2021–2026
3.2.2 Global Capecitabine Tablets Sales by Region: 2027–2032
3.3 Global Capecitabine Tablets Revenue by Region: 2021–2032
3.3.1 Global Capecitabine Tablets Revenue by Region: 2021–2026
3.3.2 Global Capecitabine Tablets Revenue by Region: 2027–2032
3.4 North America Capecitabine Tablets Market Facts & Figures by Country
3.4.1 North America Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Capecitabine Tablets Sales by Country (2021–2032)
3.4.3 North America Capecitabine Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Capecitabine Tablets Market Facts & Figures by Country
3.5.1 Europe Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Capecitabine Tablets Sales by Country (2021–2032)
3.5.3 Europe Capecitabine Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Capecitabine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Capecitabine Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Capecitabine Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Capecitabine Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Capecitabine Tablets Market Facts & Figures by Country
3.7.1 Latin America Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Capecitabine Tablets Sales by Country (2021–2032)
3.7.3 Latin America Capecitabine Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Capecitabine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Capecitabine Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Capecitabine Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Capecitabine Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Capecitabine Tablets Sales by Type (2021–2032)
4.1.1 Global Capecitabine Tablets Sales by Type (2021–2026)
4.1.2 Global Capecitabine Tablets Sales by Type (2027–2032)
4.1.3 Global Capecitabine Tablets Sales Market Share by Type (2021–2032)
4.2 Global Capecitabine Tablets Revenue by Type (2021–2032)
4.2.1 Global Capecitabine Tablets Revenue by Type (2021–2026)
4.2.2 Global Capecitabine Tablets Revenue by Type (2027–2032)
4.2.3 Global Capecitabine Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Capecitabine Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Capecitabine Tablets Sales by Application (2021–2032)
5.1.1 Global Capecitabine Tablets Sales by Application (2021–2026)
5.1.2 Global Capecitabine Tablets Sales by Application (2027–2032)
5.1.3 Global Capecitabine Tablets Sales Market Share by Application (2021–2032)
5.2 Global Capecitabine Tablets Revenue by Application (2021–2032)
5.2.1 Global Capecitabine Tablets Revenue by Application (2021–2026)
5.2.2 Global Capecitabine Tablets Revenue by Application (2027–2032)
5.2.3 Global Capecitabine Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Capecitabine Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Capecitabine Tablets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Company Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Accord Healthcare
6.3.1 Accord Healthcare Company Information
6.3.2 Accord Healthcare Description and Business Overview
6.3.3 Accord Healthcare Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Accord Healthcare Capecitabine Tablets Product Portfolio
6.3.5 Accord Healthcare Recent Developments/Updates
6.4 Dr. Reddy's Laboratories
6.4.1 Dr. Reddy's Laboratories Company Information
6.4.2 Dr. Reddy's Laboratories Description and Business Overview
6.4.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
6.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.5 Eugia Pharma
6.5.1 Eugia Pharma Company Information
6.5.2 Eugia Pharma Description and Business Overview
6.5.3 Eugia Pharma Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Eugia Pharma Capecitabine Tablets Product Portfolio
6.5.5 Eugia Pharma Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Company Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sun Pharma Capecitabine Tablets Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Qilu Pharmaceutical
6.7.1 Qilu Pharmaceutical Company Information
6.7.2 Qilu Pharmaceutical Description and Business Overview
6.7.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
6.7.5 Qilu Pharmaceutical Recent Developments/Updates
6.8 Chia Tai-Tianqing Pharmaceutical
6.8.1 Chia Tai-Tianqing Pharmaceutical Company Information
6.8.2 Chia Tai-Tianqing Pharmaceutical Description and Business Overview
6.8.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
6.8.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
6.9 Shanghai Sine Pharmaceutical
6.9.1 Shanghai Sine Pharmaceutical Company Information
6.9.2 Shanghai Sine Pharmaceutical Description and Business Overview
6.9.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
6.9.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.10 Chengdu Easton Biopharmaceuticals
6.10.1 Chengdu Easton Biopharmaceuticals Company Information
6.10.2 Chengdu Easton Biopharmaceuticals Description and Business Overview
6.10.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
6.10.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
6.11 Shandong New Time Pharmaceutical
6.11.1 Shandong New Time Pharmaceutical Company Information
6.11.2 Shandong New Time Pharmaceutical Description and Business Overview
6.11.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
6.11.5 Shandong New Time Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Capecitabine Tablets Industry Chain Analysis
7.2 Capecitabine Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Capecitabine Tablets Production Mode & Process Analysis
7.4 Capecitabine Tablets Sales and Marketing
7.4.1 Capecitabine Tablets Sales Channels
7.4.2 Capecitabine Tablets Distributors
7.5 Capecitabine Tablets Customer Analysis
8 Capecitabine Tablets Market Dynamics
8.1 Capecitabine Tablets Industry Trends
8.2 Capecitabine Tablets Market Drivers
8.3 Capecitabine Tablets Market Challenges
8.4 Capecitabine Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Capecitabine Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Capecitabine Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Capecitabine Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Capecitabine Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Capecitabine Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Capecitabine Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Capecitabine Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Capecitabine Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Capecitabine Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Capecitabine Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Capecitabine Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Capecitabine Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Capecitabine Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Capecitabine Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Capecitabine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Capecitabine Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Capecitabine Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Capecitabine Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Capecitabine Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Capecitabine Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Capecitabine Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Capecitabine Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Capecitabine Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Capecitabine Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Capecitabine Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Capecitabine Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Capecitabine Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Capecitabine Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Capecitabine Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Capecitabine Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Capecitabine Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Capecitabine Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Capecitabine Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Capecitabine Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Capecitabine Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Capecitabine Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Capecitabine Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Capecitabine Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Capecitabine Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Capecitabine Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Capecitabine Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Capecitabine Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Capecitabine Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Capecitabine Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Capecitabine Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Capecitabine Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Capecitabine Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Capecitabine Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Capecitabine Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Capecitabine Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Capecitabine Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Capecitabine Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Capecitabine Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Capecitabine Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Capecitabine Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Capecitabine Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Capecitabine Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Capecitabine Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Capecitabine Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Capecitabine Tablets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Teva Pharmaceutical Company Information
 Table 76. Teva Pharmaceutical Description and Business Overview
 Table 77. Teva Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Teva Pharmaceutical Capecitabine Tablets Product
 Table 79. Teva Pharmaceutical Recent Developments/Updates
 Table 80. Accord Healthcare Company Information
 Table 81. Accord Healthcare Description and Business Overview
 Table 82. Accord Healthcare Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Accord Healthcare Capecitabine Tablets Product
 Table 84. Accord Healthcare Recent Developments/Updates
 Table 85. Dr. Reddy's Laboratories Company Information
 Table 86. Dr. Reddy's Laboratories Description and Business Overview
 Table 87. Dr. Reddy's Laboratories Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Dr. Reddy's Laboratories Capecitabine Tablets Product
 Table 89. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 90. Eugia Pharma Company Information
 Table 91. Eugia Pharma Description and Business Overview
 Table 92. Eugia Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Eugia Pharma Capecitabine Tablets Product
 Table 94. Eugia Pharma Recent Developments/Updates
 Table 95. Sun Pharma Company Information
 Table 96. Sun Pharma Description and Business Overview
 Table 97. Sun Pharma Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Sun Pharma Capecitabine Tablets Product
 Table 99. Sun Pharma Recent Developments/Updates
 Table 100. Qilu Pharmaceutical Company Information
 Table 101. Qilu Pharmaceutical Description and Business Overview
 Table 102. Qilu Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Qilu Pharmaceutical Capecitabine Tablets Product
 Table 104. Qilu Pharmaceutical Recent Developments/Updates
 Table 105. Chia Tai-Tianqing Pharmaceutical Company Information
 Table 106. Chia Tai-Tianqing Pharmaceutical Description and Business Overview
 Table 107. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product
 Table 109. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
 Table 110. Shanghai Sine Pharmaceutical Company Information
 Table 111. Shanghai Sine Pharmaceutical Description and Business Overview
 Table 112. Shanghai Sine Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Shanghai Sine Pharmaceutical Capecitabine Tablets Product
 Table 114. Shanghai Sine Pharmaceutical Recent Developments/Updates
 Table 115. Chengdu Easton Biopharmaceuticals Company Information
 Table 116. Chengdu Easton Biopharmaceuticals Description and Business Overview
 Table 117. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product
 Table 119. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
 Table 120. Shandong New Time Pharmaceutical Company Information
 Table 121. Shandong New Time Pharmaceutical Description and Business Overview
 Table 122. Shandong New Time Pharmaceutical Capecitabine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Shandong New Time Pharmaceutical Capecitabine Tablets Product
 Table 124. Shandong New Time Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Capecitabine Tablets Distributors List
 Table 128. Capecitabine Tablets Customers List
 Table 129. Capecitabine Tablets Market Trends
 Table 130. Capecitabine Tablets Market Drivers
 Table 131. Capecitabine Tablets Market Challenges
 Table 132. Capecitabine Tablets Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Capecitabine Tablets
 Figure 2. Global Capecitabine Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Capecitabine Tablets Market Share by Type: 2025 & 2032
 Figure 4. 150mg Product Picture
 Figure 5. 500mg Product Picture
 Figure 6. Global Capecitabine Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Capecitabine Tablets Market Share by Application: 2025 & 2032
 Figure 8. Colon Cancer
 Figure 9. Breast Cancer
 Figure 10. Stomach Cancer
 Figure 11. Global Capecitabine Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Capecitabine Tablets Market Size (US$ Million), 2021–2032
 Figure 13. Global Capecitabine Tablets Sales (K Units), 2021–2032
 Figure 14. Global Capecitabine Tablets Average Price (US$/Unit), 2021–2032
 Figure 15. Capecitabine Tablets Report Years Considered
 Figure 16. Capecitabine Tablets Sales Share by Manufacturers in 2025
 Figure 17. Global Capecitabine Tablets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Capecitabine Tablets Players: Market Share by Revenue in Capecitabine Tablets in 2025
 Figure 19. Capecitabine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Capecitabine Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Capecitabine Tablets Sales Market Share by Country (2021–2032)
 Figure 22. North America Capecitabine Tablets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Capecitabine Tablets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Capecitabine Tablets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Capecitabine Tablets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Capecitabine Tablets Revenue Market Share by Region (2021–2032)
 Figure 34. China Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Capecitabine Tablets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Capecitabine Tablets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Capecitabine Tablets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Capecitabine Tablets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Capecitabine Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Capecitabine Tablets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Capecitabine Tablets by Type (2021–2032)
 Figure 54. Global Capecitabine Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Capecitabine Tablets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Capecitabine Tablets by Application (2021–2032)
 Figure 57. Global Capecitabine Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 58. Capecitabine Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc